1,3-Benzodioxolyl-N-methylpentanamine
| Names | |
|---|---|
| Preferred IUPAC name
1-(2H-1,3-Benzodioxol-5-yl)-N-methylpentan-2-amine | |
| Other names
MBDP; 3,4-Methylenedioxy-α-propyl-N-methyl-2-phenethylamine
| |
| Identifiers | |
CAS Number
|
|
3D model (JSmol)
|
|
| ChemSpider | |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
InChI
| |
SMILES
| |
| Properties | |
Chemical formula
|
C13H19NO2 |
| Molar mass | 221.30 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
1,3-Benzodioxolyl-N-methylpentanamine (N-methyl-1,3-benzodioxolylpentanamine; MBDP; methyl-K, UWA-091), also known as 3,4-methylenedioxy-α-propyl-N-methylphenethylamine, is a psychoactive drug of the phenethylamine chemical class. It is the N-methyl analogue of 1,3-benzodioxolylpentanamine (BDP; K). Methyl-K was first synthesized by Alexander Shulgin ("Sasha" Shulgin). In his book PiHKAL ("Phenethylamines i Have Known And Loved"), the minimum dosage is listed as 100 mg, and the duration is unknown.[1] Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of Methyl-K.